Provided by Tiger Trade Technology Pte. Ltd.

JD HEALTH

48.960
+0.3200.66%
Volume:5.30M
Turnover:257.42M
Market Cap:157.21B
PE:25.57
High:49.140
Open:48.640
Low:47.680
Close:48.640
52wk High:71.700
52wk Low:27.150
Shares:3.21B
HK Float Shares:3.21B
Volume Ratio:0.78
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.914
ROE:9.31%
ROA:3.11%
PB:2.30
PE(LYR):25.57
PS:1.88

Loading ...

JD Health International Stock Rises 6.6% in Hong Kong

Dow Jones
·
Nov 14, 2025

BofA Securities Raises JD Health (06618) Target Price to HK$75, Q3 Earnings Beat Expectations

Stock News
·
Nov 14, 2025

Stock Track | JD Health Soars 6.20% on Strong Q3 Results and Pharmaceutical Partnerships

Stock Track
·
Nov 14, 2025

HK Movers | JD Health Jumps Over 6% as Q3 Operating Profit Increases More Than 1.25 Times YoY

Tiger Newspress
·
Nov 14, 2025

JD.com Makes History with Record-Breaking Singles' Day Performance, Securing Industry Leadership

Deep News
·
Nov 13, 2025

JD Health International's Profit Balloons 97% in Q3

MT Newswires Live
·
Nov 13, 2025

JD Health (6618, 86618) Issues Circular on Renewing Continuing Connected Transactions with JD.com

Bulletin Express
·
Nov 13, 2025

JD Health (6618) Publishes EGM Proxy Form to Approve Four Framework Agreements with JD.com

Bulletin Express
·
Nov 13, 2025

JD Health (6618 HK/86618 RMB) Announces Extraordinary General Meeting Notice

Bulletin Express
·
Nov 13, 2025

JD Health International Inc. Announces Date for Extraordinary General Meeting

Reuters
·
Nov 13, 2025

JD HEALTH (06618) Reports Q3 Earnings with Operating Profit of RMB1.243 Billion, Up 125.3% YoY

Stock News
·
Nov 13, 2025

JD Health International Inc. Shareholders to Vote on Proxy Proposal for Renewal of Continuing Connected Transactions at Upcoming EGM

Reuters
·
Nov 13, 2025

JD Health (6618.HK, 86618.RMB) Announces Q3 2025 Unaudited Financial Update

Bulletin Express
·
Nov 13, 2025

BRIEF-JD Health International Posts Qtrly Non-IFRS Profit RMB1.90 Billion

Reuters
·
Nov 13, 2025

JD Health International Reports Strategic Partnerships and New Drug Launches in Q3 2025

Reuters
·
Nov 13, 2025

JD Health International - Qtrly Revenue RMB17.12 Bln

THOMSON REUTERS
·
Nov 13, 2025

CLOUDR (09955) Signs Service Cooperation Agreement with JD HEALTH (06618) to Expand Online Sales and Service Channels for Remifemin® and Other P2M Pipeline Products

Stock News
·
Nov 13, 2025

ClouDr Group Partners with JD Health to Expand Online Sales and Services

Reuters
·
Nov 13, 2025

ClouDr Group - Agreement to Expand Online Sales for Remifemin, Others

THOMSON REUTERS
·
Nov 13, 2025

ClouDr Group Ltd - Enters Service Cooperation Agreement With JD Health

THOMSON REUTERS
·
Nov 13, 2025